93 related articles for article (PubMed ID: 38751633)
1. Membrane mimetic-dependence of GPCR energy landscapes.
Thakur N; Ray AP; Jin B; Afsharian NP; Lyman E; Gao ZG; Jacobson KA; Eddy MT
Structure; 2024 May; 32(5):523-535.e5. PubMed ID: 38401537
[TBL] [Abstract][Full Text] [Related]
2. Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm.
Jasper JR; Insel PA
Biochem Pharmacol; 1992 Jan; 43(2):119-30. PubMed ID: 1346741
[TBL] [Abstract][Full Text] [Related]
3. Relevance of rhodopsin studies for GPCR activation.
Deupi X
Biochim Biophys Acta; 2014 May; 1837(5):674-82. PubMed ID: 24041646
[TBL] [Abstract][Full Text] [Related]
4. Structural Insights into Partial Activation of the Prototypic G Protein-Coupled Adenosine A
Claff T; Mahardhika AB; Vaaßen VJ; Schlegel JG; Vielmuth C; Weiße RH; Sträter N; Müller CE
ACS Pharmacol Transl Sci; 2024 May; 7(5):1415-1425. PubMed ID: 38751633
[TBL] [Abstract][Full Text] [Related]
5. A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptor.
Lane JR; Klein Herenbrink C; van Westen GJ; Spoorendonk JA; Hoffmann C; IJzerman AP
Mol Pharmacol; 2012 Mar; 81(3):475-87. PubMed ID: 22188926
[TBL] [Abstract][Full Text] [Related]
6. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
Ye L; Van Eps N; Zimmer M; Ernst OP; Prosser RS
Nature; 2016 May; 533(7602):265-8. PubMed ID: 27144352
[TBL] [Abstract][Full Text] [Related]
7. Insights into adenosine A2A receptor activation through cooperative modulation of agonist and allosteric lipid interactions.
Bruzzese A; Dalton JAR; Giraldo J
PLoS Comput Biol; 2020 Apr; 16(4):e1007818. PubMed ID: 32298258
[TBL] [Abstract][Full Text] [Related]
8. Cancer-Associated Mutations of the Adenosine A
Feng C; Wang X; Jespers W; Liu R; Zamarbide Losada SD; Gorostiola González M; van Westen GJP; Danen EHJ; Heitman LH
Molecules; 2022 Jul; 27(15):. PubMed ID: 35897852
[TBL] [Abstract][Full Text] [Related]
9. Purinergic receptors in cognitive disturbances.
Illes P; Ulrich H; Chen JF; Tang Y
Neurobiol Dis; 2023 Sep; 185():106229. PubMed ID: 37453562
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of adenosine A
Claff T; Schlegel JG; Voss JH; Vaaßen VJ; Weiße RH; Cheng RKY; Markovic-Mueller S; Bucher D; Sträter N; Müller CE
Commun Chem; 2023 Jun; 6(1):106. PubMed ID: 37264098
[TBL] [Abstract][Full Text] [Related]
11. Sub-millisecond conformational dynamics of the A
Maslov I; Volkov O; Khorn P; Orekhov P; Gusach A; Kuzmichev P; Gerasimov A; Luginina A; Coucke Q; Bogorodskiy A; Gordeliy V; Wanninger S; Barth A; Mishin A; Hofkens J; Cherezov V; Gensch T; Hendrix J; Borshchevskiy V
Commun Biol; 2023 Apr; 6(1):362. PubMed ID: 37012383
[TBL] [Abstract][Full Text] [Related]
12. In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A
Ohno Y; Suzuki M; Asada H; Kanda T; Saki M; Miyagi H; Yasunaga M; Suno C; Iwata S; Saito JI; Uchida S
Mol Pharmacol; 2023 Jun; 103(6):311-324. PubMed ID: 36894319
[TBL] [Abstract][Full Text] [Related]
13. Structures of adenosine receptor A
Cai H; Xu Y; Guo S; He X; Sun J; Li X; Li C; Yin W; Cheng X; Jiang H; Xu HE; Xie X; Jiang Y
Cell Discov; 2022 Dec; 8(1):140. PubMed ID: 36575181
[No Abstract] [Full Text] [Related]
14. The role of adenosine A
Launay A; Nebie O; Vijaya Shankara J; Lebouvier T; Buée L; Faivre E; Blum D
Neuropharmacology; 2023 Mar; 226():109379. PubMed ID: 36572177
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
